Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Saved in:
Bibliographic Details
Title: Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.
Authors: Karakus KE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Chesshir L; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Walker S; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Baschal EE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., McDaniel KA; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Triolo TM; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Steck AK; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Frohnert BI; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Gottlieb PA; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Michels AW; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Simmons KM; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA. Kimber.simmons@cuanschutz.edu.
Source: Diabetologia [Diabetologia] 2026 May; Vol. 69 (5), pp. 1164-1175. Date of Electronic Publication: 2026 Jan 15.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0428
DOI:10.1007/s00125-025-06646-6